FdaApplication
NDA 020401
Identifiers
- fda_app_no: NDA020401
Properties
| Property | Value |
|---|---|
| applicant_name | BAUSCH HEALTH US LLC |
| application_type | NDA |
| approval_date | 1995-09-11 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 420MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 240MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 180MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 360MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TIAZAC | DILTIAZEM HYDROCHLORIDE | 300MG | CAPSULE, EXTENDED RELEASE;ORAL |
6 products